Pioneering the next frontier of metabolic health, the biotech company works to develop revolutionary, safe, and effective products that address imbalances in the microbiome, transforming people's lives from the inside out
The absence of side effects makes DSIP a particularly attractive option for those who have experienced unwanted symptoms from traditional sleep medications
Experimental data indicate that GHK-Cu can influence collagen and glycosaminoglycan synthesis, modulate proteoglycan and chondroitin sulfate turnover, and recruit fibroblasts, immune cells, and endothelial cells to sites of tissue injury
CrossRef Long-term efficacy of dapagliflozin combined with Bifidobacterium triple viable tablets on metabolic syndrome and gut microbiota in overweight/obese patients with type 2 diabetes Kunyi Li, Zhi Li, Lifeng Liu Endocrine Connections.2025;[Epub] CrossRef Pharmacotherapy Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning Jung A Kim, Hye Jin Yoo Diabetes Metab J
PMID: 19126664
